Posted in | News | Nanomedicine | Nanomaterials

Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects

Whether triggered by cats, bees, pollen or mites, allergies are on the rise. And the bad news doesn't stop there. The only current therapy that treats their causes is allergen-specific immunotherapy -- or allergy shots -- which can cause severe side effects. Now, researchers report in Biomacromolecules the development of a potentially better allergy shot that uses nanocarriers to address these unwanted issues.

For many people, allergies are a seasonal annoyance. But for others, exposure to a particular allergen can cause adverse reactions such as itching, breathing problems or even death. Allergy shots can reduce sensitivity by slowly ramping up exposure to the offending substance. But because these shots expose the body to the very thing people are allergic to, the treatment itself can sometimes trigger reactions. In order to develop a safer, more direct, cause-based therapy, researchers have developed nanoparticles that envelop an allergen and deliver it to specific cells. But these carriers degrade too slowly, hampering the effectiveness of the treatment. Holger Frey and colleagues set out to overcome these limitations.

The researchers designed a new type of nanocarrier based on the biocompatible molecule poly(ethylene glycol), or PEG, that releases its cargo only in targeted immune cells. The nanocarrier degrades when it encounters the acidic part of these cells, simultaneously releasing the allergen and getting rid of the packaging. The researchers say this approach also could be used for vaccines or immunotherapies for other conditions such as cancer or AIDS.

Source: http://www.acs.org/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    American Chemical Society. (2019, February 11). Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects. AZoNano. Retrieved on May 21, 2024 from https://www.azonano.com/news.aspx?newsID=33805.

  • MLA

    American Chemical Society. "Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects". AZoNano. 21 May 2024. <https://www.azonano.com/news.aspx?newsID=33805>.

  • Chicago

    American Chemical Society. "Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects". AZoNano. https://www.azonano.com/news.aspx?newsID=33805. (accessed May 21, 2024).

  • Harvard

    American Chemical Society. 2019. Researchers Develop Allergy Shot that Uses Nanocarriers to Reduce Severe Side Effects. AZoNano, viewed 21 May 2024, https://www.azonano.com/news.aspx?newsID=33805.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.